John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency
You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …
Pharma losing in ‘valley of death’
February 21, 2013Research and Development, Sales and Marketing Bath, Evotec, pharma
An academic from Bath University has warned that much of pharma’s most promising research is being lost before it can …
Lundbeck elects new chairman
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck
Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down. Pettersson, a …
SHL to invest 40 Million USD in 2013 to significantly expand production facilities
February 21, 2013Manufacturing and Production auto injectors, autoinjector, drug delivery, pen injectors
SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices …
NHS Confederation appoints two directors
February 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, confederation
The NHS Confederation has announced the appointment of two new directors to the organisation. Dr Johnny Marshall (pictured) and Matt …
FDA accepts GSK’s Anoro
February 20, 2013Research and Development, Sales and Marketing FDA, GSK, Theravance, anoro
The FDA has accepted a New Drug Application for GlaxoSmithKline and biopharma firm Theravance’s investigational COPD drug UMEC/VI. A decision …
Phytopharm suffers Parkinson’s loss
February 20, 2013Research and Development, Sales and Marketing Parkinson's, Phytopharm, cogane
Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …
Strategic North launches thought leaders book
February 20, 2013Medical Communications Strategic North, health policy
A healthcare consultancy has launched a book collecting thoughts and insights from experts in health and beyond.Strategic North, a strategic …
Director-level role hire at Insight Research Group
February 20, 2013Medical Communications, Research and Development, Sales and Marketing Insight Research Group, carolyn dodd
Carolyn Dodd has taken up a director-level position at healthcare consultancy firm Insight Research Group. Dodd previously spent 12 years …
VBP negotiations ‘opened up’
February 19, 2013Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP
Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …
Vasella forgoes golden handshake after furore
February 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella
Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …
GSK plans greater use of biocatalysis, continuous processing
February 19, 2013Manufacturing and Production GSK, Witty, biocatalysis
GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …
inVentiv Health names new European head
February 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentic Health
Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …
EU orphan designations rise
February 19, 2013Research and Development, Sales and Marketing COMP, EMA, Orphan, hta
The number of orphan drug designations in the EU is set to rise to record levels this year, according to …
New director at Havas PR
February 19, 2013Medical Communications Havas, Louise Stone, PR
Havas PR has brought in healthcare consultant Louise Stone to strengthen its health and wellness business. Louise takes on the role …
Genzyme’s Waterford plant gets new investment round
February 19, 2013Manufacturing and Production Genzyme, Sanofi, Waterford
Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …
Gilead recalls Vistide on particle contamination
February 19, 2013Manufacturing and Production Gilead, Vistide
Gilead Sciences has issued a voluntary recall of one lot of its antiviral treatment Vistide after finding particulate matter in …
CMO plant shut down after Takeda product recall
February 19, 2013Manufacturing and Production CMP, OPG, Takeda
Japan’s regulatory authorities flexed their enforcement muscles last week when it ordered a temporary shutdown of the contract manufacturer for …
ViiV HIV drug boost
February 18, 2013Sales and Marketing Dolutegravir, GSK, HIV, ViiV
ViiV Healthcare has received a boost with the news that the FDA is to give a priority review to its …
Merck makes $688m payout
February 18, 2013Sales and Marketing ENHANCE, Inegy, Merck, Vytorin, investors
Merck has paid out $688 million to end two class-action lawsuits which sprang up after the revelation of disappointing trial …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
